Sponsor or institution
Clinical trials and research at Universidad Central Del Caribe
As of November 12, 2026, Find a Trial lists 12 NIH-funded research projects at this institution, with $1.8 million in listed awards. Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 12NIH research projects
NIH-funded research (12)
Early-stage science funded by the US National Institutes of Health. Most of these projects don't enroll patients, but they show what is being worked on.
-
Targeted breast cancer treatment using a natural product to block cancer cell survival
A patient-friendly look at a grant that supports testing a natural compound that may stop a tough type of breast cancer from thriving.
-
Ultracentrifuge for separating small molecules, compounds, and vesicles
A new ultracentrifuge will be bought for a shared core facility to speed up high-precision separation of tiny particles and molecules for multiple biomedical research projects.
-
Blocking Pyk2 to help immune therapy work better for glioblastoma
Seeing if stopping a protein called Pyk2 can make immune checkpoint drugs (like PD-L1 blockers) work better for people with glioblastoma.
-
Beta-amyloid build-up in the brain for Parkinson's disease
This research explores how a protein called amyloid beta, often linked to Alzheimer's, builds up in the brains of people with Parkinson's disease, especially when dementia develops.
-
Understanding how beta-amyloid builds up in the brain of Parkinson's disease patients
This study is looking at how a substance called amyloid beta builds up in the brains of people with Parkinson's disease as they start to experience dementia, and it aims to find out how this buildup happens and what role blood cells and inflammation play in the process.
-
Investigating how ergosterol peroxide can selectively inhibit aggressive breast cancer
This study is looking at how a natural compound from fungi, called ergosterol peroxide, can help fight triple-negative breast cancer by killing cancer cells without harming normal cells, with the hope of creating a new treatment option for patients facing this tough type of cancer.
-
Blocking Pyk2 to improve immune therapy for aggressive brain cancer
This study is looking at how blocking a protein called Pyk2 might help make glioblastoma, a tough brain cancer, more sensitive to treatments that use the immune system, so that patients can have better responses to their therapies.
-
Annual meeting to improve cancer research in Puerto Rico
The Puerto Rico Cancer Research Meeting is a friendly gathering where local scientists, students, and patient advocates come together to share ideas and support each other in cancer research, with a special focus on including diverse voices in the conversation.
-
Investigating the role of glial cells and polyamines in brain health and diseases.
This study is looking at how natural substances in the brain called polyamines affect the health of brain support cells and their connection to diseases like Alzheimer's and Parkinson's, with the hope of finding new ways to protect against memory loss and brain injuries as we age.
-
Understanding how beta-amyloid builds up in the brain of Parkinson's disease patients
This study is looking at how a substance called amyloid beta builds up in the brains of people with Parkinson's disease who also have dementia, and it wants to find out if platelets in the blood play a role in this process, which could help us discover new ways to treat these conditions.
-
Investigating how Pyk2 affects immune cells and vesicle release in aggressive brain tumors.
This study is looking at how a protein called Pyk2 affects the immune response in glioblastoma, a tough type of brain cancer, to find new ways to improve treatment for patients like you.
-
Investigating SCAMP3's role in aggressive breast cancer
This study is looking at a protein called SCAMP3 that is found in higher amounts in triple-negative breast cancer, to see how it affects the growth of the cancer and to find new ways to treat patients with this type of breast cancer.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.